Skip to main content
Journal ArticleOPEN ACCESS

General practitioner knowledge gaps regarding live attenuated zoster vaccination of immunocompromised individuals

Australian Journal of General Practice (2022) 51(7) 529-534
DOI: 10.31128/AJGP-09-21-6175
2Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Background and objective Live attenuated herpes zoster vaccine (Zostavax [CSL/Merck]) was included on the Australian National Immunisation Program from 1 November 2016 for adults aged 70 years, with a catch-up program for adults aged 71–79 years. The aim of this study was to assess the knowledge of Australian general practitioners (GPs) regarding Zostavax.

Cite

CITATION STYLE

APA

Dey, A., Rashid, H., Sharma, K., Phillips, A., Li-Kim-Moy, J., Manocha, R., … Beard, F. (2022). General practitioner knowledge gaps regarding live attenuated zoster vaccination of immunocompromised individuals. Australian Journal of General Practice, 51(7), 529–534. https://doi.org/10.31128/AJGP-09-21-6175

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free